Can Dopamine Responsiveness Be Predicted ...
Document type :
Article dans une revue scientifique: Article original
DOI :
PMID :
Permalink :
Title :
Can Dopamine Responsiveness Be Predicted in Parkinson's Disease Without an Acute Administration Test?
Author(s) :
Betrouni, Nacim [Auteur]
Lille Neurosciences & Cognition (LilNCog) - U 1172
Moreau, caroline [Auteur]
Lille Neurosciences & Cognition (LilNCog) - U 1172
Rolland, Anne-Sophie [Auteur]
Lille Neurosciences & Cognition - U 1172 [LilNCog]
Carrière, N. [Auteur]
Viard, Romain [Auteur]
Lille Neurosciences & Cognition (LilNCog) - U 1172
Plateformes Lilloises en Biologie et Santé (PLBS) - UAR 2014 - US 41
Lopes, Renaud [Auteur]
Lille Neurosciences & Cognition (LilNCog) - U 1172
Lille in vivo imaging and Functional Exploration - PLBS [LiiFE]
Kuchcinski, Gregory [Auteur]
Plateformes Lilloises en Biologie et Santé - UAR 2014 - US 41 [PLBS]
Lille Neurosciences & Cognition (LilNCog) - U 1172
Eusebio, A. [Auteur]
Thobois, S. [Auteur]
Hainque, E. [Auteur]
Hubsch, C. [Auteur]
Rascol, O. [Auteur]
Brefel, C. [Auteur]
Drapier, S. [Auteur]
Giordana, C. [Auteur]
Durif, F. [Auteur]
Maltête, D. [Auteur]
Guehl, D. [Auteur]
Hopes, L. [Auteur]
Rouaud, T. [Auteur]
Jarraya, B. [Auteur]
Benatru, I. [Auteur]
Tranchant, C. [Auteur]
Tir, M. [Auteur]
Chupin, M. [Auteur]
Bardinet, E. [Auteur]
Defebvre, L. [Auteur]
Corvol, J. C. [Auteur]
Devos, David [Auteur]
Lille Neurosciences & Cognition (LilNCog) - U 1172
Lille Neurosciences & Cognition (LilNCog) - U 1172
Moreau, caroline [Auteur]
Lille Neurosciences & Cognition (LilNCog) - U 1172
Rolland, Anne-Sophie [Auteur]
Lille Neurosciences & Cognition - U 1172 [LilNCog]
Carrière, N. [Auteur]
Viard, Romain [Auteur]
Lille Neurosciences & Cognition (LilNCog) - U 1172
Plateformes Lilloises en Biologie et Santé (PLBS) - UAR 2014 - US 41
Lopes, Renaud [Auteur]
Lille Neurosciences & Cognition (LilNCog) - U 1172
Lille in vivo imaging and Functional Exploration - PLBS [LiiFE]
Kuchcinski, Gregory [Auteur]
Plateformes Lilloises en Biologie et Santé - UAR 2014 - US 41 [PLBS]
Lille Neurosciences & Cognition (LilNCog) - U 1172
Eusebio, A. [Auteur]
Thobois, S. [Auteur]
Hainque, E. [Auteur]
Hubsch, C. [Auteur]
Rascol, O. [Auteur]
Brefel, C. [Auteur]
Drapier, S. [Auteur]
Giordana, C. [Auteur]
Durif, F. [Auteur]
Maltête, D. [Auteur]
Guehl, D. [Auteur]
Hopes, L. [Auteur]
Rouaud, T. [Auteur]
Jarraya, B. [Auteur]
Benatru, I. [Auteur]
Tranchant, C. [Auteur]
Tir, M. [Auteur]
Chupin, M. [Auteur]
Bardinet, E. [Auteur]
Defebvre, L. [Auteur]
Corvol, J. C. [Auteur]
Devos, David [Auteur]
Lille Neurosciences & Cognition (LilNCog) - U 1172
Journal title :
J Parkinsons Dis
Abbreviated title :
J Parkinsons Dis
Volume number :
12
Pages :
p. 2179-2190
Publication date :
2022
ISSN :
1877-718X
English keyword(s) :
Dopamine
dopa-sensitivity
prediction modelling
MRI
dopa-sensitivity
prediction modelling
MRI
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
Background: Dopamine responsiveness (dopa-sensitivity) is an important parameter in the management of patients with Parkinson’s disease (PD). For quantification of this parameter, patients undergo a challenge test with ...
Show more >Background: Dopamine responsiveness (dopa-sensitivity) is an important parameter in the management of patients with Parkinson’s disease (PD). For quantification of this parameter, patients undergo a challenge test with acute Levodopa administration after drug withdrawal, which may lead to patient discomfort and use of significant resources. Objective: Our objective was to develop a predictive model combining clinical scores and imaging. Methods: 350 patients, recruited by 13 specialist French centers and considered for deep brain stimulation, underwent an acute L-dopa challenge (dopa-sensitivity > 30%), full assessment, and MRI investigations, including T1w and R2* images. Data were randomly divided into a learning base from 10 centers and data from the remaining centers for testing. A machine selection approach was applied to choose the optimal variables and these were then used in regression modeling. Complexity of the modelling was incremental, while the first model considered only clinical variables, the subsequent included imaging features. The performances were evaluated by comparing the estimated values and actual values Results: Whatever the model, the variables age, sex, disease duration, and motor scores were selected as contributors. The first model used them and the coefficients of determination (R2) was 0.60 for the testing set and 0.69 in the learning set (p < 0.001). The models that added imaging features enhanced the performances: with T1w (R2 = 0.65 and 0.76, p < 0.001) and with R2* (R2 = 0.60 and 0.72, p < 0.001). Conclusion: These results suggest that modeling is potentially a simple way to estimate dopa-sensitivity, but requires confirmation in a larger population, including patients with dopa-sensitivity < 30%Show less >
Show more >Background: Dopamine responsiveness (dopa-sensitivity) is an important parameter in the management of patients with Parkinson’s disease (PD). For quantification of this parameter, patients undergo a challenge test with acute Levodopa administration after drug withdrawal, which may lead to patient discomfort and use of significant resources. Objective: Our objective was to develop a predictive model combining clinical scores and imaging. Methods: 350 patients, recruited by 13 specialist French centers and considered for deep brain stimulation, underwent an acute L-dopa challenge (dopa-sensitivity > 30%), full assessment, and MRI investigations, including T1w and R2* images. Data were randomly divided into a learning base from 10 centers and data from the remaining centers for testing. A machine selection approach was applied to choose the optimal variables and these were then used in regression modeling. Complexity of the modelling was incremental, while the first model considered only clinical variables, the subsequent included imaging features. The performances were evaluated by comparing the estimated values and actual values Results: Whatever the model, the variables age, sex, disease duration, and motor scores were selected as contributors. The first model used them and the coefficients of determination (R2) was 0.60 for the testing set and 0.69 in the learning set (p < 0.001). The models that added imaging features enhanced the performances: with T1w (R2 = 0.65 and 0.76, p < 0.001) and with R2* (R2 = 0.60 and 0.72, p < 0.001). Conclusion: These results suggest that modeling is potentially a simple way to estimate dopa-sensitivity, but requires confirmation in a larger population, including patients with dopa-sensitivity < 30%Show less >
Language :
Anglais
Peer reviewed article :
Oui
Audience :
Internationale
Popular science :
Non
Collections :
Research team(s) :
Lille in vivo imaging and Functional Exploration (LiiFE)
Submission date :
2023-12-21T06:47:33Z
2024-02-23T11:53:05Z
2024-02-23T11:53:05Z
Files
- document
- Open access
- Access the document